

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 8.99589206 |
| 2 | hair cycle (GO:0042633) | 8.23432814 |
| 3 | molting cycle (GO:0042303) | 8.23432814 |
| 4 | cilium or flagellum-dependent cell motility (GO:0001539) | 7.79974798 |
| 5 | cilium movement (GO:0003341) | 7.10537705 |
| 6 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.86917663 |
| 7 | keratinization (GO:0031424) | 6.71988405 |
| 8 | epithelial cilium movement (GO:0003351) | 6.29301653 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.81005058 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 5.81005058 |
| 11 | motile cilium assembly (GO:0044458) | 5.79090430 |
| 12 | axoneme assembly (GO:0035082) | 5.69085292 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 5.68913966 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.58742930 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.58742930 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.58742930 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 5.47293196 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.47293196 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.33887868 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.17555716 |
| 21 | gap junction assembly (GO:0016264) | 5.08489618 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.05749737 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.02473935 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.95024668 |
| 25 | fibrinolysis (GO:0042730) | 4.82094432 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.79188476 |
| 27 | regulation of complement activation (GO:0030449) | 4.73517507 |
| 28 | urea metabolic process (GO:0019627) | 4.68175362 |
| 29 | urea cycle (GO:0000050) | 4.68175362 |
| 30 | fatty acid elongation (GO:0030497) | 4.65204791 |
| 31 | desmosome organization (GO:0002934) | 4.60752956 |
| 32 | glyoxylate metabolic process (GO:0046487) | 4.51076175 |
| 33 | protein carboxylation (GO:0018214) | 4.49990377 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.49990377 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.49468664 |
| 36 | synaptic vesicle maturation (GO:0016188) | 4.49207705 |
| 37 | regulation of cilium movement (GO:0003352) | 4.48290734 |
| 38 | establishment of skin barrier (GO:0061436) | 4.47227909 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 4.39047741 |
| 40 | bile acid metabolic process (GO:0008206) | 4.31764614 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.23912426 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 4.23349430 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.17251861 |
| 44 | alpha-linolenic acid metabolic process (GO:0036109) | 4.16837812 |
| 45 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.14515792 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.13661554 |
| 47 | skin morphogenesis (GO:0043589) | 4.13057963 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 4.10275461 |
| 49 | glutamate secretion (GO:0014047) | 4.08722644 |
| 50 | phospholipid efflux (GO:0033700) | 4.05971311 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 4.03298460 |
| 52 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.99646399 |
| 53 | neurotransmitter secretion (GO:0007269) | 3.95743003 |
| 54 | intermediate filament organization (GO:0045109) | 3.93417343 |
| 55 | hemidesmosome assembly (GO:0031581) | 3.92187158 |
| 56 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.91992120 |
| 57 | cysteine metabolic process (GO:0006534) | 3.90559147 |
| 58 | protein localization to cilium (GO:0061512) | 3.90193333 |
| 59 | imidazole-containing compound metabolic process (GO:0052803) | 3.89363654 |
| 60 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.88218818 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.84133292 |
| 62 | sulfur amino acid catabolic process (GO:0000098) | 3.83643894 |
| 63 | bile acid and bile salt transport (GO:0015721) | 3.83434478 |
| 64 | amine catabolic process (GO:0009310) | 3.82827465 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 3.82827465 |
| 66 | tyrosine metabolic process (GO:0006570) | 3.81542380 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 3.80979874 |
| 68 | synaptic vesicle exocytosis (GO:0016079) | 3.78031364 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 3.77509002 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 3.76244089 |
| 71 | regulation of water loss via skin (GO:0033561) | 3.76115610 |
| 72 | reverse cholesterol transport (GO:0043691) | 3.68230909 |
| 73 | coenzyme catabolic process (GO:0009109) | 3.67219356 |
| 74 | central nervous system myelination (GO:0022010) | 3.64321301 |
| 75 | axon ensheathment in central nervous system (GO:0032291) | 3.64321301 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.62321620 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.60106338 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.59864419 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.59864419 |
| 80 | regulation of microtubule-based movement (GO:0060632) | 3.59049624 |
| 81 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.57874727 |
| 82 | protein activation cascade (GO:0072376) | 3.54278779 |
| 83 | linoleic acid metabolic process (GO:0043651) | 3.53776320 |
| 84 | complement activation (GO:0006956) | 3.53685830 |
| 85 | plasma lipoprotein particle remodeling (GO:0034369) | 3.53563176 |
| 86 | protein-lipid complex remodeling (GO:0034368) | 3.53563176 |
| 87 | macromolecular complex remodeling (GO:0034367) | 3.53563176 |
| 88 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.53463034 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 3.53147072 |
| 90 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.52368156 |
| 91 | microtubule bundle formation (GO:0001578) | 3.52229903 |
| 92 | very long-chain fatty acid metabolic process (GO:0000038) | 3.51886021 |
| 93 | vocalization behavior (GO:0071625) | 3.51491019 |
| 94 | cholesterol efflux (GO:0033344) | 3.49685288 |
| 95 | alpha-amino acid catabolic process (GO:1901606) | 3.49492780 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.41298179 |
| 97 | negative regulation of hemostasis (GO:1900047) | 3.38257468 |
| 98 | negative regulation of blood coagulation (GO:0030195) | 3.38257468 |
| 99 | cytolysis (GO:0019835) | 3.37781825 |
| 100 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.37000016 |
| 101 | cilium organization (GO:0044782) | 3.35411008 |
| 102 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.35097461 |
| 103 | regulation of synapse structural plasticity (GO:0051823) | 3.35016610 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 3.34174781 |
| 105 | amino-acid betaine metabolic process (GO:0006577) | 3.33343399 |
| 106 | serine family amino acid catabolic process (GO:0009071) | 3.33159018 |
| 107 | left/right pattern formation (GO:0060972) | 3.32882311 |
| 108 | synaptic transmission, glutamatergic (GO:0035249) | 3.31940784 |
| 109 | benzene-containing compound metabolic process (GO:0042537) | 3.30802356 |
| 110 | lysine catabolic process (GO:0006554) | 3.28703378 |
| 111 | lysine metabolic process (GO:0006553) | 3.28703378 |
| 112 | transmission of nerve impulse (GO:0019226) | 3.28204780 |
| 113 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.28170607 |
| 114 | cilium assembly (GO:0042384) | 3.26677261 |
| 115 | arginine metabolic process (GO:0006525) | 3.25150451 |
| 116 | complement activation, classical pathway (GO:0006958) | 3.24650517 |
| 117 | neuronal action potential propagation (GO:0019227) | 3.23041230 |
| 118 | regulation of cholesterol esterification (GO:0010872) | 3.22869437 |
| 119 | glutamate metabolic process (GO:0006536) | 3.21864772 |
| 120 | purine ribonucleotide transport (GO:0015868) | 3.20652742 |
| 121 | drug catabolic process (GO:0042737) | 3.17850587 |
| 122 | cellular amino acid catabolic process (GO:0009063) | 3.16235202 |
| 123 | negative regulation of sterol transport (GO:0032372) | 3.16088131 |
| 124 | negative regulation of cholesterol transport (GO:0032375) | 3.16088131 |
| 125 | cellular glucuronidation (GO:0052695) | 3.14706660 |
| 126 | phospholipid homeostasis (GO:0055091) | 3.14706223 |
| 127 | purine nucleotide transport (GO:0015865) | 3.14322127 |
| 128 | exogenous drug catabolic process (GO:0042738) | 3.13837041 |
| 129 | neurotransmitter transport (GO:0006836) | 3.12576044 |
| 130 | cofactor catabolic process (GO:0051187) | 3.11122097 |
| 131 | peptide cross-linking (GO:0018149) | 3.10962536 |
| 132 | negative regulation of wound healing (GO:0061045) | 3.09043815 |
| 133 | negative regulation of lipase activity (GO:0060192) | 3.08096610 |
| 134 | glutamate receptor signaling pathway (GO:0007215) | 3.07508992 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 3.07384248 |
| 136 | negative regulation of coagulation (GO:0050819) | 3.06528999 |
| 137 | ventricular system development (GO:0021591) | 3.04319171 |
| 138 | one-carbon compound transport (GO:0019755) | 2.98546244 |
| 139 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.93141335 |
| 140 | auditory behavior (GO:0031223) | 2.91485210 |
| 141 | neuron-neuron synaptic transmission (GO:0007270) | 2.90620997 |
| 142 | regulation of synaptic vesicle transport (GO:1902803) | 2.89366159 |
| 143 | membrane depolarization during action potential (GO:0086010) | 2.88074183 |
| 144 | neuron cell-cell adhesion (GO:0007158) | 2.86691839 |
| 145 | retinal cone cell development (GO:0046549) | 2.84958808 |
| 146 | intraciliary transport (GO:0042073) | 2.84239749 |
| 147 | proline transport (GO:0015824) | 2.81408456 |
| 148 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.80488860 |
| 149 | primary alcohol catabolic process (GO:0034310) | 2.77457539 |
| 150 | dendritic spine morphogenesis (GO:0060997) | 2.77397407 |
| 151 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.74077537 |
| 152 | negative regulation of inclusion body assembly (GO:0090084) | 2.72964901 |
| 153 | protein localization to synapse (GO:0035418) | 2.72836986 |
| 154 | neurotransmitter catabolic process (GO:0042135) | 2.72759435 |
| 155 | cilium morphogenesis (GO:0060271) | 2.71883215 |
| 156 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.71076375 |
| 157 | regulation of vesicle fusion (GO:0031338) | 2.70418366 |
| 158 | left/right axis specification (GO:0070986) | 2.70032242 |
| 159 | neuronal action potential (GO:0019228) | 2.68883502 |
| 160 | ethanol metabolic process (GO:0006067) | 2.67506821 |
| 161 | locomotory exploration behavior (GO:0035641) | 2.66485613 |
| 162 | detection of calcium ion (GO:0005513) | 2.66346377 |
| 163 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.65772224 |
| 164 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.64216446 |
| 165 | primary amino compound metabolic process (GO:1901160) | 2.63946844 |
| 166 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.63475051 |
| 167 | positive regulation of membrane potential (GO:0045838) | 2.62572067 |
| 168 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.60048797 |
| 169 | regulation of germinal center formation (GO:0002634) | 2.59096522 |
| 170 | cochlea development (GO:0090102) | 2.57846759 |
| 171 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.57375842 |
| 172 | serotonin metabolic process (GO:0042428) | 2.56903749 |
| 173 | phosphorelay signal transduction system (GO:0000160) | 2.56171384 |
| 174 | response to amphetamine (GO:0001975) | 2.55732231 |
| 175 | vitamin transmembrane transport (GO:0035461) | 2.55555107 |
| 176 | cellular potassium ion homeostasis (GO:0030007) | 2.53353013 |
| 177 | exploration behavior (GO:0035640) | 2.52509144 |
| 178 | postsynaptic membrane organization (GO:0001941) | 2.52425549 |
| 179 | potassium ion transmembrane transport (GO:0071805) | 2.52385620 |
| 180 | cellular potassium ion transport (GO:0071804) | 2.52385620 |
| 181 | urinary tract smooth muscle contraction (GO:0014848) | 2.52154564 |
| 182 | glycosphingolipid biosynthetic process (GO:0006688) | 2.51753655 |
| 183 | neurotransmitter metabolic process (GO:0042133) | 2.51443119 |
| 184 | lung epithelium development (GO:0060428) | 2.51184740 |
| 185 | neuromuscular process controlling posture (GO:0050884) | 2.50601311 |
| 186 | cellular ketone body metabolic process (GO:0046950) | 2.49754622 |
| 187 | positive regulation of vesicle fusion (GO:0031340) | 2.48683367 |
| 188 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.48569759 |
| 189 | synaptic transmission (GO:0007268) | 2.48347866 |
| 190 | regulation of neurotransmitter transport (GO:0051588) | 2.44922667 |
| 191 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.44662379 |
| 192 | potassium ion homeostasis (GO:0055075) | 2.43767359 |
| 193 | behavioral response to nicotine (GO:0035095) | 2.43681025 |
| 194 | cerebellar granule cell differentiation (GO:0021707) | 2.42387274 |
| 195 | membrane depolarization (GO:0051899) | 2.42368447 |
| 196 | regulation of neurotransmitter secretion (GO:0046928) | 2.41593433 |
| 197 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.41517575 |
| 198 | positive regulation of neurotransmitter transport (GO:0051590) | 2.41273937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.49936953 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.71217508 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.08257027 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.46433822 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.41280081 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18337805 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89276992 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.35693070 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.11742984 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.08034226 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.05210609 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.67509828 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47173542 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.46842163 |
| 15 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.28587448 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.26248168 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07042816 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86806979 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82149296 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.82130503 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.81212556 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80896712 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80053269 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79405061 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79276335 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.76025022 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72228586 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72095228 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69978660 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65113600 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61933606 |
| 32 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.60369816 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56164547 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52242684 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49583014 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43416118 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41647314 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41647314 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39312856 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38600073 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38019784 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37983895 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37178893 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36841901 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31195818 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30921603 |
| 47 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30131624 |
| 48 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28630010 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27086347 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25900863 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25676005 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25286817 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25245621 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24479982 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24323333 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23457388 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22673567 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22065949 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21286647 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19807292 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18120013 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17214823 |
| 63 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16561227 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16551821 |
| 65 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15177882 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14911796 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14668272 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14653550 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14256925 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13205318 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13127396 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13094288 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07570573 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07110900 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05469965 |
| 76 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05441877 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04309091 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03781075 |
| 79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03353262 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03254453 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02863795 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02863795 |
| 83 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02422206 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01920047 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01282320 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01282320 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01063983 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00304216 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99424129 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99188791 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99102782 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99072357 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98571746 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95694103 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94646713 |
| 96 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94591142 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94425453 |
| 98 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94192642 |
| 99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93530630 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93528362 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93097560 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92082039 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91787835 |
| 104 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91380280 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91198697 |
| 106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91198697 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91049781 |
| 108 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90933190 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90933190 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90909432 |
| 111 | AR_19668381_ChIP-Seq_PC3_Human | 0.90718430 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90700146 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90238164 |
| 114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90137862 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89980999 |
| 116 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89833708 |
| 117 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89499222 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89380831 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89273010 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88715249 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87751727 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86722858 |
| 123 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86690277 |
| 124 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86165187 |
| 125 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84935360 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84934223 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84736061 |
| 128 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84525721 |
| 129 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.84200076 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83917896 |
| 131 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.83495535 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83120536 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83026842 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82316432 |
| 135 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81452999 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81112620 |
| 137 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80903962 |
| 138 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79888674 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79767673 |
| 140 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78542299 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.78368579 |
| 142 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77829177 |
| 143 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77636695 |
| 144 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77521048 |
| 145 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77065759 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76717822 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76596292 |
| 148 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75018292 |
| 149 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74033898 |
| 150 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74033898 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73922280 |
| 152 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72902294 |
| 153 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72251480 |
| 154 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.71634243 |
| 155 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.70911117 |
| 156 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70505655 |
| 157 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.69723836 |
| 158 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.69270983 |
| 159 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69223181 |
| 160 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.68911156 |
| 161 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68883607 |
| 162 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68836162 |
| 163 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.68550699 |
| 164 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.67960750 |
| 165 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.67921945 |
| 166 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.67174736 |
| 167 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.66833654 |
| 168 | RXR_22108803_ChIP-Seq_LS180_Human | 0.65538203 |
| 169 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.64945903 |
| 170 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.64189836 |
| 171 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.64189836 |
| 172 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.63713520 |
| 173 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63449100 |
| 174 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.63410811 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63049627 |
| 176 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.62979514 |
| 177 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62564992 |
| 178 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.62277813 |
| 179 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.62114234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000579_abnormal_nail_morphology | 5.91606500 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.56171631 |
| 3 | MP0005360_urolithiasis | 5.14659745 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.84351119 |
| 5 | MP0002796_impaired_skin_barrier | 4.76435212 |
| 6 | MP0005365_abnormal_bile_salt | 4.40025920 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.75610778 |
| 8 | MP0003880_abnormal_central_pattern | 3.56288825 |
| 9 | MP0005275_abnormal_skin_tensile | 3.29352402 |
| 10 | MP0002653_abnormal_ependyma_morphology | 3.27475509 |
| 11 | MP0004381_abnormal_hair_follicle | 3.16402714 |
| 12 | MP0000467_abnormal_esophagus_morphology | 3.06755463 |
| 13 | MP0009745_abnormal_behavioral_response | 3.01036186 |
| 14 | MP0003252_abnormal_bile_duct | 2.96149747 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.88362940 |
| 16 | MP0002064_seizures | 2.80948047 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.77551600 |
| 18 | MP0009046_muscle_twitch | 2.71501557 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.68891586 |
| 20 | MP0004270_analgesia | 2.66649618 |
| 21 | MP0005501_abnormal_skin_physiology | 2.64915510 |
| 22 | MP0002272_abnormal_nervous_system | 2.56803085 |
| 23 | MP0001984_abnormal_olfaction | 2.44753571 |
| 24 | MP0001486_abnormal_startle_reflex | 2.44617677 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.39441820 |
| 26 | MP0010329_abnormal_lipoprotein_level | 2.35175830 |
| 27 | MP0002063_abnormal_learning/memory/cond | 2.34753092 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 2.34588731 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.31018311 |
| 30 | MP0001501_abnormal_sleep_pattern | 2.27963291 |
| 31 | MP0002735_abnormal_chemical_nociception | 2.23371009 |
| 32 | MP0002254_reproductive_system_inflammat | 2.19030525 |
| 33 | MP0002060_abnormal_skin_morphology | 2.12557000 |
| 34 | MP0005423_abnormal_somatic_nervous | 2.09916125 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 2.09581179 |
| 36 | MP0001216_abnormal_epidermal_layer | 2.03392838 |
| 37 | MP0000647_abnormal_sebaceous_gland | 2.01503905 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 2.01097602 |
| 39 | MP0000383_abnormal_hair_follicle | 2.00040165 |
| 40 | MP0003787_abnormal_imprinting | 1.99109661 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.93630742 |
| 42 | MP0001970_abnormal_pain_threshold | 1.90990439 |
| 43 | MP0002736_abnormal_nociception_after | 1.83658917 |
| 44 | MP0005451_abnormal_body_composition | 1.83526539 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.82477336 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.80106537 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.79710788 |
| 48 | MP0004947_skin_inflammation | 1.78488501 |
| 49 | MP0000377_abnormal_hair_follicle | 1.77198474 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.73838858 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.73040624 |
| 52 | MP0004133_heterotaxia | 1.72963689 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 1.72735868 |
| 54 | MP0005083_abnormal_biliary_tract | 1.72455712 |
| 55 | MP0004043_abnormal_pH_regulation | 1.71376480 |
| 56 | MP0010771_integument_phenotype | 1.70787572 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.70613073 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.69185830 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.68895698 |
| 60 | MP0009840_abnormal_foam_cell | 1.68768879 |
| 61 | MP0001905_abnormal_dopamine_level | 1.65686246 |
| 62 | MP0003195_calcinosis | 1.65020755 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.63687684 |
| 64 | MP0008877_abnormal_DNA_methylation | 1.63122783 |
| 65 | MP0005332_abnormal_amino_acid | 1.61751813 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.59967108 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.57071406 |
| 68 | MP0000427_abnormal_hair_cycle | 1.55608660 |
| 69 | MP0000762_abnormal_tongue_morphology | 1.53678696 |
| 70 | MP0003868_abnormal_feces_composition | 1.52873883 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.52577823 |
| 72 | MP0002067_abnormal_sensory_capabilities | 1.52568685 |
| 73 | MP0004142_abnormal_muscle_tone | 1.51665943 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.50720723 |
| 75 | MP0008872_abnormal_physiological_respon | 1.43406528 |
| 76 | MP0000609_abnormal_liver_physiology | 1.41896736 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 1.41212202 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.39104771 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 1.38812930 |
| 80 | MP0005409_darkened_coat_color | 1.36403733 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.33871750 |
| 82 | MP0004924_abnormal_behavior | 1.33871750 |
| 83 | MP0001440_abnormal_grooming_behavior | 1.33225727 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.32918947 |
| 85 | MP0003633_abnormal_nervous_system | 1.30894852 |
| 86 | MP0002822_catalepsy | 1.30474946 |
| 87 | MP0008569_lethality_at_weaning | 1.29831917 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 1.27900825 |
| 89 | MP0003879_abnormal_hair_cell | 1.26046863 |
| 90 | MP0006054_spinal_hemorrhage | 1.21346583 |
| 91 | MP0000604_amyloidosis | 1.20959804 |
| 92 | MP0004742_abnormal_vestibular_system | 1.20752224 |
| 93 | MP0002229_neurodegeneration | 1.20110376 |
| 94 | MP0000569_abnormal_digit_pigmentation | 1.19598732 |
| 95 | MP0006276_abnormal_autonomic_nervous | 1.18149050 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 1.13046647 |
| 97 | MP0003724_increased_susceptibility_to | 1.11617303 |
| 98 | MP0003631_nervous_system_phenotype | 1.11548418 |
| 99 | MP0001243_abnormal_dermal_layer | 1.11197833 |
| 100 | MP0002102_abnormal_ear_morphology | 1.11120564 |
| 101 | MP0003329_amyloid_beta_deposits | 1.11057285 |
| 102 | MP0002066_abnormal_motor_capabilities/c | 1.10815143 |
| 103 | MP0002882_abnormal_neuron_morphology | 1.10259210 |
| 104 | MP0000955_abnormal_spinal_cord | 1.09371225 |
| 105 | MP0001963_abnormal_hearing_physiology | 1.07307992 |
| 106 | MP0010386_abnormal_urinary_bladder | 1.06631356 |
| 107 | MP0000778_abnormal_nervous_system | 1.05963697 |
| 108 | MP0009764_decreased_sensitivity_to | 1.05264856 |
| 109 | MP0009931_abnormal_skin_appearance | 1.02483733 |
| 110 | MP0000367_abnormal_coat/_hair | 1.01434307 |
| 111 | MP0003878_abnormal_ear_physiology | 1.00721281 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 1.00721281 |
| 113 | MP0001765_abnormal_ion_homeostasis | 1.00257313 |
| 114 | MP0002184_abnormal_innervation | 0.99541819 |
| 115 | MP0005253_abnormal_eye_physiology | 0.99320940 |
| 116 | MP0001529_abnormal_vocalization | 0.97898954 |
| 117 | MP0003122_maternal_imprinting | 0.96908100 |
| 118 | MP0004811_abnormal_neuron_physiology | 0.96576420 |
| 119 | MP0002132_abnormal_respiratory_system | 0.95049622 |
| 120 | MP0000566_synostosis | 0.94206612 |
| 121 | MP0003011_delayed_dark_adaptation | 0.93558727 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.93523259 |
| 123 | MP0003136_yellow_coat_color | 0.92600702 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.91066583 |
| 125 | MP0000026_abnormal_inner_ear | 0.90859660 |
| 126 | MP0005670_abnormal_white_adipose | 0.89486157 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.88568525 |
| 128 | MP0003632_abnormal_nervous_system | 0.88034077 |
| 129 | MP0008438_abnormal_cutaneous_collagen | 0.85226400 |
| 130 | MP0000631_abnormal_neuroendocrine_gland | 0.84603453 |
| 131 | MP0001851_eye_inflammation | 0.82633204 |
| 132 | MP0005647_abnormal_sex_gland | 0.82387617 |
| 133 | MP0002282_abnormal_trachea_morphology | 0.81816118 |
| 134 | MP0003075_altered_response_to | 0.81687237 |
| 135 | MP0001191_abnormal_skin_condition | 0.80521305 |
| 136 | MP0000920_abnormal_myelination | 0.79029959 |
| 137 | MP0006072_abnormal_retinal_apoptosis | 0.78958579 |
| 138 | MP0003436_decreased_susceptibility_to | 0.78821175 |
| 139 | MP0003283_abnormal_digestive_organ | 0.78509566 |
| 140 | MP0004147_increased_porphyrin_level | 0.77720318 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.76011551 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.75842825 |
| 143 | MP0005167_abnormal_blood-brain_barrier | 0.75747701 |
| 144 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75268215 |
| 145 | MP0002752_abnormal_somatic_nervous | 0.74394231 |
| 146 | MP0005499_abnormal_olfactory_system | 0.73695932 |
| 147 | MP0005394_taste/olfaction_phenotype | 0.73695932 |
| 148 | MP0005023_abnormal_wound_healing | 0.71154503 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.70711824 |
| 150 | MP0009053_abnormal_anal_canal | 0.70098211 |
| 151 | MP0003045_fibrosis | 0.69763542 |
| 152 | MP0008789_abnormal_olfactory_epithelium | 0.69617000 |
| 153 | MP0002152_abnormal_brain_morphology | 0.69566057 |
| 154 | MP0003938_abnormal_ear_development | 0.69172500 |
| 155 | MP0001346_abnormal_lacrimal_gland | 0.68833556 |
| 156 | MP0001944_abnormal_pancreas_morphology | 0.67994868 |
| 157 | MP0005666_abnormal_adipose_tissue | 0.67255238 |
| 158 | MP0008469_abnormal_protein_level | 0.65794984 |
| 159 | MP0001764_abnormal_homeostasis | 0.65656488 |
| 160 | MP0009763_increased_sensitivity_to | 0.65112845 |
| 161 | MP0009643_abnormal_urine_homeostasis | 0.63953736 |
| 162 | MP0004782_abnormal_surfactant_physiolog | 0.62752405 |
| 163 | MP0005165_increased_susceptibility_to | 0.60519253 |
| 164 | MP0005535_abnormal_body_temperature | 0.58848593 |
| 165 | MP0004130_abnormal_muscle_cell | 0.57874224 |
| 166 | MP0003941_abnormal_skin_development | 0.57851589 |
| 167 | MP0000598_abnormal_liver_morphology | 0.57042602 |
| 168 | MP0009384_cardiac_valve_regurgitation | 0.54232632 |
| 169 | MP0002332_abnormal_exercise_endurance | 0.54150996 |
| 170 | MP0004885_abnormal_endolymph | 0.51546237 |
| 171 | MP0000465_gastrointestinal_hemorrhage | 0.48991604 |
| 172 | MP0002234_abnormal_pharynx_morphology | 0.48954401 |
| 173 | MP0009642_abnormal_blood_homeostasis | 0.48086989 |
| 174 | MP0001661_extended_life_span | 0.47647034 |
| 175 | MP0002971_abnormal_brown_adipose | 0.46947265 |
| 176 | MP0003690_abnormal_glial_cell | 0.46463169 |
| 177 | MP0006138_congestive_heart_failure | 0.45192836 |
| 178 | MP0003303_peritoneal_inflammation | 0.44542976 |
| 179 | MP0005595_abnormal_vascular_smooth | 0.42004957 |
| 180 | MP0001756_abnormal_urination | 0.41460728 |
| 181 | MP0005464_abnormal_platelet_physiology | 0.41232141 |
| 182 | MP0001340_abnormal_eyelid_morphology | 0.40977884 |
| 183 | MP0002928_abnormal_bile_duct | 0.39620092 |
| 184 | MP0002896_abnormal_bone_mineralization | 0.37649812 |
| 185 | MP0002090_abnormal_vision | 0.36548759 |
| 186 | MP0000627_abnormal_mammary_gland | 0.36308901 |
| 187 | MP0000767_abnormal_smooth_muscle | 0.36264040 |
| 188 | MP0010368_abnormal_lymphatic_system | 0.35491721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nail color (HP:0100643) | 9.02432883 |
| 2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 8.54422940 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 7.84405383 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 7.84405383 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 7.76762338 |
| 6 | Abnormal respiratory epithelium morphology (HP:0012253) | 7.76762338 |
| 7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 7.45637234 |
| 8 | Abnormal ciliary motility (HP:0012262) | 7.44370900 |
| 9 | Rhinitis (HP:0012384) | 6.88423225 |
| 10 | Thick nail (HP:0001805) | 6.71417119 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 5.90028756 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 5.52950243 |
| 13 | Alopecia of scalp (HP:0002293) | 5.31410709 |
| 14 | Deep venous thrombosis (HP:0002625) | 5.16297720 |
| 15 | Chronic bronchitis (HP:0004469) | 4.99375771 |
| 16 | Bronchiectasis (HP:0002110) | 4.86399766 |
| 17 | Palmoplantar hyperkeratosis (HP:0000972) | 4.83175660 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.78446061 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.67223704 |
| 20 | Complement deficiency (HP:0004431) | 4.64043289 |
| 21 | Xanthomatosis (HP:0000991) | 4.57508298 |
| 22 | Plantar hyperkeratosis (HP:0007556) | 4.54091765 |
| 23 | Palmar hyperkeratosis (HP:0010765) | 4.50684103 |
| 24 | Hypotrichosis (HP:0001006) | 4.35704775 |
| 25 | Oral leukoplakia (HP:0002745) | 4.23674512 |
| 26 | Increased IgE level (HP:0003212) | 4.06678926 |
| 27 | Nasal polyposis (HP:0100582) | 3.96458364 |
| 28 | Epidermoid cyst (HP:0200040) | 3.90728861 |
| 29 | Focal motor seizures (HP:0011153) | 3.88512504 |
| 30 | Pancreatic fibrosis (HP:0100732) | 3.86775368 |
| 31 | Joint hemorrhage (HP:0005261) | 3.81982584 |
| 32 | True hermaphroditism (HP:0010459) | 3.79521693 |
| 33 | Woolly hair (HP:0002224) | 3.74856537 |
| 34 | Myocardial infarction (HP:0001658) | 3.73805734 |
| 35 | Follicular hyperkeratosis (HP:0007502) | 3.73301962 |
| 36 | Pancreatic cysts (HP:0001737) | 3.71967657 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 3.56251342 |
| 38 | Onycholysis (HP:0001806) | 3.46728730 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 3.46285034 |
| 40 | Fat malabsorption (HP:0002630) | 3.43833974 |
| 41 | Abnormality of complement system (HP:0005339) | 3.39762020 |
| 42 | Nephronophthisis (HP:0000090) | 3.35304877 |
| 43 | Molar tooth sign on MRI (HP:0002419) | 3.33343695 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 3.33343695 |
| 45 | Focal seizures (HP:0007359) | 3.30430081 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14340318 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 3.14152578 |
| 48 | Cystic liver disease (HP:0006706) | 3.09099061 |
| 49 | Fragile nails (HP:0001808) | 3.06260271 |
| 50 | Myokymia (HP:0002411) | 3.05761668 |
| 51 | Chronic sinusitis (HP:0011109) | 3.05680596 |
| 52 | Occipital encephalocele (HP:0002085) | 3.05056058 |
| 53 | Milia (HP:0001056) | 3.04669955 |
| 54 | Febrile seizures (HP:0002373) | 3.04555127 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 3.04437908 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 3.03999934 |
| 57 | Hypolipoproteinemia (HP:0010981) | 3.01067516 |
| 58 | Neonatal onset (HP:0003623) | 2.97085627 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.96763896 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.95732417 |
| 61 | Epileptic encephalopathy (HP:0200134) | 2.95560261 |
| 62 | Erythroderma (HP:0001019) | 2.95412505 |
| 63 | Bronchitis (HP:0012387) | 2.84834791 |
| 64 | Infertility (HP:0000789) | 2.78099452 |
| 65 | Metaphyseal dysplasia (HP:0100255) | 2.75842307 |
| 66 | Ketosis (HP:0001946) | 2.75699690 |
| 67 | Steatorrhea (HP:0002570) | 2.74401467 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 2.71931449 |
| 69 | Limb dystonia (HP:0002451) | 2.71543880 |
| 70 | Spontaneous abortion (HP:0005268) | 2.70376247 |
| 71 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69997468 |
| 72 | Nail dystrophy (HP:0008404) | 2.69138217 |
| 73 | Medial flaring of the eyebrow (HP:0010747) | 2.69117577 |
| 74 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.68746262 |
| 75 | Abnormality of the renal medulla (HP:0100957) | 2.66337167 |
| 76 | Gait imbalance (HP:0002141) | 2.65825709 |
| 77 | Pili torti (HP:0003777) | 2.64571229 |
| 78 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62014420 |
| 79 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60049731 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.57761101 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.57625593 |
| 82 | Abnormal blistering of the skin (HP:0008066) | 2.57559334 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.51141299 |
| 84 | Atonic seizures (HP:0010819) | 2.50416994 |
| 85 | Hyperammonemia (HP:0001987) | 2.50002153 |
| 86 | Progressive cerebellar ataxia (HP:0002073) | 2.48689353 |
| 87 | Recurrent bacterial skin infections (HP:0005406) | 2.39955155 |
| 88 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38990324 |
| 89 | Erythema (HP:0010783) | 2.36929405 |
| 90 | Recurrent otitis media (HP:0000403) | 2.35733166 |
| 91 | Chronic otitis media (HP:0000389) | 2.33215136 |
| 92 | Absent speech (HP:0001344) | 2.32745714 |
| 93 | Palmoplantar keratoderma (HP:0000982) | 2.31948920 |
| 94 | Ridged nail (HP:0001807) | 2.31542329 |
| 95 | Dialeptic seizures (HP:0011146) | 2.31254690 |
| 96 | Hyperglycinemia (HP:0002154) | 2.31147781 |
| 97 | Abnormal drinking behavior (HP:0030082) | 2.31092847 |
| 98 | Polydipsia (HP:0001959) | 2.31092847 |
| 99 | Chronic hepatic failure (HP:0100626) | 2.30277407 |
| 100 | Abnormal hair laboratory examination (HP:0003328) | 2.28812169 |
| 101 | Hypoglycemic coma (HP:0001325) | 2.27411391 |
| 102 | Laryngomalacia (HP:0001601) | 2.27225655 |
| 103 | Hyperglycinuria (HP:0003108) | 2.26401187 |
| 104 | Pruritus (HP:0000989) | 2.25420317 |
| 105 | Tubular atrophy (HP:0000092) | 2.25160637 |
| 106 | Abnormality of glycine metabolism (HP:0010895) | 2.24426577 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.24426577 |
| 108 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.23025823 |
| 109 | Skin nodule (HP:0200036) | 2.22280080 |
| 110 | Congenital hepatic fibrosis (HP:0002612) | 2.19563145 |
| 111 | Congenital primary aphakia (HP:0007707) | 2.18269580 |
| 112 | Polyphagia (HP:0002591) | 2.17414665 |
| 113 | Prostate neoplasm (HP:0100787) | 2.17194879 |
| 114 | Hyperactive renin-angiotensin system (HP:0000841) | 2.15975277 |
| 115 | Absence seizures (HP:0002121) | 2.15687277 |
| 116 | Conjunctival hamartoma (HP:0100780) | 2.14836929 |
| 117 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14171669 |
| 118 | Hemiparesis (HP:0001269) | 2.10195335 |
| 119 | Polycythemia (HP:0001901) | 2.09941691 |
| 120 | Gangrene (HP:0100758) | 2.09893841 |
| 121 | Hyperventilation (HP:0002883) | 2.09557533 |
| 122 | Congenital stationary night blindness (HP:0007642) | 2.08353855 |
| 123 | Generalized tonic-clonic seizures (HP:0002069) | 2.07043534 |
| 124 | Postaxial foot polydactyly (HP:0001830) | 2.06089660 |
| 125 | Furrowed tongue (HP:0000221) | 2.04331274 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 2.04233383 |
| 127 | Anencephaly (HP:0002323) | 2.04212084 |
| 128 | Abnormality of renin-angiotensin system (HP:0000847) | 2.02949369 |
| 129 | Abnormal eating behavior (HP:0100738) | 2.02825846 |
| 130 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01368680 |
| 131 | Sleep apnea (HP:0010535) | 2.01129753 |
| 132 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.01050865 |
| 133 | Glomerulonephritis (HP:0000099) | 2.00932103 |
| 134 | Decreased central vision (HP:0007663) | 1.99620057 |
| 135 | Male pseudohermaphroditism (HP:0000037) | 1.98383804 |
| 136 | Spastic diplegia (HP:0001264) | 1.97444605 |
| 137 | Hyperbilirubinemia (HP:0002904) | 1.95837459 |
| 138 | Eczematoid dermatitis (HP:0000976) | 1.92298810 |
| 139 | Broad-based gait (HP:0002136) | 1.92259730 |
| 140 | Gingival bleeding (HP:0000225) | 1.91651915 |
| 141 | Torticollis (HP:0000473) | 1.91050986 |
| 142 | Neonatal respiratory distress (HP:0002643) | 1.89746629 |
| 143 | Vascular calcification (HP:0004934) | 1.89692305 |
| 144 | Ankle clonus (HP:0011448) | 1.89230256 |
| 145 | Abnormality of binocular vision (HP:0011514) | 1.89184530 |
| 146 | Diplopia (HP:0000651) | 1.89184530 |
| 147 | Renal cortical cysts (HP:0000803) | 1.87863106 |
| 148 | Neurofibrillary tangles (HP:0002185) | 1.87075470 |
| 149 | Amyloidosis (HP:0011034) | 1.87009690 |
| 150 | Abnormality of the parietal bone (HP:0002696) | 1.86692330 |
| 151 | Hyperaldosteronism (HP:0000859) | 1.86382226 |
| 152 | Corneal erosion (HP:0200020) | 1.85965661 |
| 153 | Status epilepticus (HP:0002133) | 1.85850163 |
| 154 | Esophageal varix (HP:0002040) | 1.85350112 |
| 155 | Papilledema (HP:0001085) | 1.85049051 |
| 156 | Ketoacidosis (HP:0001993) | 1.84671948 |
| 157 | Abnormality of nucleobase metabolism (HP:0010932) | 1.84185620 |
| 158 | Sclerocornea (HP:0000647) | 1.81857364 |
| 159 | Male infertility (HP:0003251) | 1.81731979 |
| 160 | Progressive external ophthalmoplegia (HP:0000590) | 1.80111156 |
| 161 | Peritonitis (HP:0002586) | 1.79382460 |
| 162 | Mutism (HP:0002300) | 1.79279102 |
| 163 | Corneal dystrophy (HP:0001131) | 1.77973162 |
| 164 | Brittle hair (HP:0002299) | 1.77839485 |
| 165 | Hyporeflexia of lower limbs (HP:0002600) | 1.77305618 |
| 166 | Abnormality of macular pigmentation (HP:0008002) | 1.76938875 |
| 167 | Cardiovascular calcification (HP:0011915) | 1.76897109 |
| 168 | Stroke (HP:0001297) | 1.75930547 |
| 169 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75605816 |
| 170 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75037238 |
| 171 | Spinal cord lesions (HP:0100561) | 1.74503102 |
| 172 | Syringomyelia (HP:0003396) | 1.74503102 |
| 173 | Visual hallucinations (HP:0002367) | 1.73455412 |
| 174 | Menorrhagia (HP:0000132) | 1.73294091 |
| 175 | Abnormal gallbladder morphology (HP:0012437) | 1.71888566 |
| 176 | Renal salt wasting (HP:0000127) | 1.71665288 |
| 177 | Asplenia (HP:0001746) | 1.71391493 |
| 178 | Ventricular fibrillation (HP:0001663) | 1.71037974 |
| 179 | Type II lissencephaly (HP:0007260) | 1.70788498 |
| 180 | Hypokalemic alkalosis (HP:0001949) | 1.69484163 |
| 181 | Hypohidrosis (HP:0000966) | 1.69369365 |
| 182 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.68266728 |
| 183 | Cholelithiasis (HP:0001081) | 1.67915631 |
| 184 | Focal dystonia (HP:0004373) | 1.67815785 |
| 185 | Genital tract atresia (HP:0001827) | 1.67657850 |
| 186 | Vaginal atresia (HP:0000148) | 1.66907378 |
| 187 | Epileptiform EEG discharges (HP:0011182) | 1.66023281 |
| 188 | Gaze-evoked nystagmus (HP:0000640) | 1.65710000 |
| 189 | Urticaria (HP:0001025) | 1.64846575 |
| 190 | Hemiplegia (HP:0002301) | 1.61707466 |
| 191 | Increased circulating renin level (HP:0000848) | 1.60867028 |
| 192 | Postaxial hand polydactyly (HP:0001162) | 1.60704490 |
| 193 | Bile duct proliferation (HP:0001408) | 1.60305983 |
| 194 | Abnormal biliary tract physiology (HP:0012439) | 1.60305983 |
| 195 | Large for gestational age (HP:0001520) | 1.59717921 |
| 196 | Polyuria (HP:0000103) | 1.59714082 |
| 197 | Prolonged QT interval (HP:0001657) | 1.57657926 |
| 198 | Supranuclear gaze palsy (HP:0000605) | 1.57400698 |
| 199 | Nephropathy (HP:0000112) | 1.57274901 |
| 200 | EEG with generalized epileptiform discharges (HP:0011198) | 1.56208342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.50486718 |
| 2 | PIK3CG | 4.19153423 |
| 3 | MST1R | 3.77439139 |
| 4 | MARK1 | 3.40373707 |
| 5 | FGFR4 | 3.01261792 |
| 6 | EPHA4 | 2.97295892 |
| 7 | MAPK13 | 2.87230039 |
| 8 | NTRK3 | 2.87120687 |
| 9 | SIK1 | 2.74306409 |
| 10 | ERBB4 | 2.36713484 |
| 11 | PINK1 | 2.23293125 |
| 12 | BCKDK | 2.12581180 |
| 13 | FRK | 2.08660259 |
| 14 | UHMK1 | 2.08132532 |
| 15 | PAK6 | 2.01211900 |
| 16 | TYK2 | 1.92771023 |
| 17 | ADRBK2 | 1.88430704 |
| 18 | TAOK3 | 1.82310537 |
| 19 | PNCK | 1.80750098 |
| 20 | CAMKK1 | 1.78783033 |
| 21 | MYLK | 1.77171987 |
| 22 | MAPK11 | 1.72302009 |
| 23 | MAP3K4 | 1.68779863 |
| 24 | MET | 1.62684236 |
| 25 | INSRR | 1.58999314 |
| 26 | FER | 1.58007018 |
| 27 | CDK6 | 1.57926255 |
| 28 | DMPK | 1.57888205 |
| 29 | CAMKK2 | 1.52072718 |
| 30 | PAK2 | 1.51548953 |
| 31 | JAK3 | 1.49939904 |
| 32 | WNK3 | 1.44391605 |
| 33 | OXSR1 | 1.44309297 |
| 34 | CSK | 1.44249475 |
| 35 | RIPK1 | 1.40649460 |
| 36 | PRKCG | 1.39110450 |
| 37 | MAP3K6 | 1.31344633 |
| 38 | OBSCN | 1.30803117 |
| 39 | MINK1 | 1.30577678 |
| 40 | MAP4K2 | 1.30163745 |
| 41 | NME1 | 1.27532207 |
| 42 | MAP2K4 | 1.26469772 |
| 43 | TRIB3 | 1.23264506 |
| 44 | JAK1 | 1.21975098 |
| 45 | PLK2 | 1.20325172 |
| 46 | MAP3K14 | 1.19020272 |
| 47 | CASK | 1.18335885 |
| 48 | GRK5 | 1.18199963 |
| 49 | MST4 | 1.14048128 |
| 50 | BLK | 1.11651759 |
| 51 | MAP2K7 | 1.10882625 |
| 52 | TTN | 1.10730733 |
| 53 | CAMK1 | 1.10237022 |
| 54 | PKN1 | 1.09616598 |
| 55 | CDK19 | 1.09330789 |
| 56 | TXK | 1.08472867 |
| 57 | MAPKAPK3 | 1.07903265 |
| 58 | MAPKAPK5 | 1.07802646 |
| 59 | ZAP70 | 1.06231130 |
| 60 | MAPK4 | 1.05527881 |
| 61 | JAK2 | 1.03340555 |
| 62 | DYRK2 | 1.02895680 |
| 63 | PTK2B | 1.01662924 |
| 64 | CDK5 | 0.99204179 |
| 65 | PRKD3 | 0.98139741 |
| 66 | CAMK2A | 0.97961891 |
| 67 | CAMK1D | 0.97577063 |
| 68 | MAP3K7 | 0.94652624 |
| 69 | BMX | 0.92943510 |
| 70 | IRAK3 | 0.91108590 |
| 71 | LATS1 | 0.88295879 |
| 72 | FLT3 | 0.86432392 |
| 73 | PHKG2 | 0.85981675 |
| 74 | PHKG1 | 0.85981675 |
| 75 | EPHB1 | 0.85447705 |
| 76 | ERBB2 | 0.85374702 |
| 77 | NEK9 | 0.83945348 |
| 78 | PRKCE | 0.83785578 |
| 79 | WNK4 | 0.83712255 |
| 80 | PRKCH | 0.83599049 |
| 81 | PRKCZ | 0.82248406 |
| 82 | EPHB2 | 0.80808622 |
| 83 | MARK2 | 0.79384561 |
| 84 | RET | 0.78259504 |
| 85 | PAK3 | 0.78102679 |
| 86 | IKBKB | 0.78016230 |
| 87 | TNIK | 0.76401323 |
| 88 | MAPK12 | 0.75705629 |
| 89 | IKBKE | 0.74737934 |
| 90 | SGK494 | 0.74547159 |
| 91 | SGK223 | 0.74547159 |
| 92 | PTK2 | 0.73909762 |
| 93 | RIPK4 | 0.73684516 |
| 94 | CAMK2B | 0.73582105 |
| 95 | DAPK3 | 0.73448112 |
| 96 | PTK6 | 0.72727710 |
| 97 | TAOK1 | 0.72364681 |
| 98 | GRK6 | 0.71794981 |
| 99 | DAPK1 | 0.71765414 |
| 100 | KDR | 0.69073018 |
| 101 | MAP3K2 | 0.68633460 |
| 102 | PRKACG | 0.68468626 |
| 103 | DAPK2 | 0.67651584 |
| 104 | FGFR1 | 0.67194234 |
| 105 | BMPR1B | 0.67146718 |
| 106 | NEK6 | 0.66092078 |
| 107 | PRKCQ | 0.65389882 |
| 108 | MAP2K1 | 0.65238070 |
| 109 | SGK1 | 0.63768859 |
| 110 | PRKAA2 | 0.63403332 |
| 111 | MAP3K1 | 0.63185251 |
| 112 | TNK2 | 0.62827300 |
| 113 | PRKCI | 0.62549445 |
| 114 | ABL2 | 0.62042307 |
| 115 | GRK1 | 0.61916173 |
| 116 | STK38 | 0.61409521 |
| 117 | FGFR2 | 0.61353914 |
| 118 | TBK1 | 0.61253259 |
| 119 | PDPK1 | 0.61170324 |
| 120 | MAP3K12 | 0.59366550 |
| 121 | YES1 | 0.58972039 |
| 122 | CAMK2G | 0.58796086 |
| 123 | GRK7 | 0.58450942 |
| 124 | PIK3CA | 0.58098801 |
| 125 | STK39 | 0.57515273 |
| 126 | STK11 | 0.56522539 |
| 127 | NTRK2 | 0.56088547 |
| 128 | PKN2 | 0.55858313 |
| 129 | CSNK1G2 | 0.55573954 |
| 130 | CAMK1G | 0.55402175 |
| 131 | PRKCA | 0.55296470 |
| 132 | LATS2 | 0.54883869 |
| 133 | MAP3K8 | 0.54759984 |
| 134 | TLK1 | 0.51368306 |
| 135 | ADRBK1 | 0.50348903 |
| 136 | SIK2 | 0.50193175 |
| 137 | CSNK1D | 0.49630384 |
| 138 | MAPK15 | 0.48744383 |
| 139 | FGFR3 | 0.47135316 |
| 140 | KIT | 0.46210980 |
| 141 | EPHA2 | 0.46113434 |
| 142 | CAMK4 | 0.45582580 |
| 143 | MAP2K6 | 0.45251509 |
| 144 | CAMK2D | 0.43574307 |
| 145 | ROCK1 | 0.43378927 |
| 146 | CSNK1A1 | 0.43112733 |
| 147 | MAP2K2 | 0.42997326 |
| 148 | ABL1 | 0.42086948 |
| 149 | PRKG1 | 0.41120415 |
| 150 | SYK | 0.41055635 |
| 151 | TIE1 | 0.40482508 |
| 152 | SGK2 | 0.40093568 |
| 153 | RPS6KA3 | 0.40078208 |
| 154 | RPS6KL1 | 0.39939455 |
| 155 | RPS6KC1 | 0.39939455 |
| 156 | TGFBR2 | 0.39921811 |
| 157 | DYRK1A | 0.38077606 |
| 158 | RPS6KA2 | 0.37668334 |
| 159 | FES | 0.37582108 |
| 160 | NTRK1 | 0.37438779 |
| 161 | MAP3K11 | 0.36506853 |
| 162 | PRKACA | 0.35617746 |
| 163 | PDK1 | 0.34663926 |
| 164 | PRKAA1 | 0.33758117 |
| 165 | ERBB3 | 0.33170196 |
| 166 | MAP3K9 | 0.32749036 |
| 167 | LIMK1 | 0.32264389 |
| 168 | CDK3 | 0.31578344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.83748235 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.77442846 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33019824 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12816378 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03690733 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.01956339 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64153977 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63303921 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.60481542 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58469361 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33015410 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30765240 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.27770475 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17949525 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15091494 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.13008523 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11008050 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.10731495 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 2.08736715 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.04792620 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.03859380 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03572154 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02478068 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01449326 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.99403602 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95244126 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94399431 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.92210669 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.91399023 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.90872940 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87976338 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84977886 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.80600088 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79926801 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79820645 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77172804 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.72639628 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.70815629 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67831302 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64526365 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.63339741 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.62098210 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61446870 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60330062 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55568692 |
| 46 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.55332631 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54045527 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51761554 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51632671 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46343774 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43224998 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.40815114 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34406831 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33178571 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33115645 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32441325 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30566607 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28402917 |
| 59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26261323 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25953022 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22872548 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.22847243 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18466804 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15537299 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14563204 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12876108 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09865527 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09500419 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05814025 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05071275 |
| 71 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.04713843 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 1.04124943 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01374527 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97275032 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97112093 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96292298 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95679849 |
| 78 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95670356 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92906061 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92762286 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90690881 |
| 82 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88962027 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.88169636 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87414037 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86214006 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85627989 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84488923 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82378826 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80997637 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.79986892 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79101352 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78809618 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77931417 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77513602 |
| 95 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75301717 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75012900 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74597030 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74355886 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73342262 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.72957430 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70995113 |
| 102 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69055556 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66272352 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65455970 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65203834 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65134800 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64488049 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63305097 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62781691 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61673226 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58060626 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55057843 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53180306 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52770749 |
| 115 | Axon guidance_Homo sapiens_hsa04360 | 0.47715401 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47699003 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47626202 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44097188 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43638267 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42850518 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41048696 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41018635 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.39780589 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39726747 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37612873 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.35223012 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35164100 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34774510 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32910834 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30627540 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.30619166 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30130368 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25469930 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22816335 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21131784 |
| 136 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20122156 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.19262859 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16511452 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15949185 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15682380 |
| 141 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.14727460 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14119066 |
| 143 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.11352280 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.09527404 |
| 145 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07430693 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.03600169 |
| 147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.01883900 |
| 148 | Malaria_Homo sapiens_hsa05144 | 0.01747830 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01126530 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | 0.00118181 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0780569 |
| 152 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0775866 |
| 153 | Adherens junction_Homo sapiens_hsa04520 | -0.0745585 |
| 154 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0568747 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0491667 |
| 156 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0297678 |
| 157 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0296534 |
| 158 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0213329 |
| 159 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0146257 |

